Education
About Us
Working with TipRanks
Follow Us
Nuo Therapeutics Inc (AURX)
:AURX
AURX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.25 - $1.93
Previous CloseN/A
Volume8.36K
Average Volume (3M)19.36K
Market Cap
$74.02M
Enterprise Value$65.64M
Total Cash (Recent Filing)$55.66K
Total Debt (Recent Filing)$148.11K
Price to Earnings (P/E)―
Beta0.02
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding46,823,180
10 Day Avg. Volume47,685
30 Day Avg. Volume19,356
Financial Highlights & Ratios
PEG Ratio3.59
Price to Book (P/B)-307.61
Price to Sales (P/S)0.00
P/FCF Ratio-31.94
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue12.68
Enterprise Value/Gross Profit52.87
Enterprise Value/Ebitda-6.68
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Nuo Therapeutics News
PremiumCompany Announcements
Nuo Therapeutics Amends Distribution Agreement with Smith+Nephew
PremiumCompany Announcements
Nuo Therapeutics Delays Annual Report Filing
PremiumCompany Announcements
Nuo Therapeutics Announces Annual Report Filing DelayOptions Prices
Currently, No data available
---
Ownership Overview
41.96% Insiders
―
Mutual Funds
― Other Institutional Investors
58.04% Public Companies and
Individual Investors
AURX FAQ
What was Nuo Therapeutics Inc’s price range in the past 12 months?
Nuo Therapeutics Inc lowest stock price was $0.25 and its highest was $1.93 in the past 12 months.
What is Nuo Therapeutics Inc’s market cap?
Nuo Therapeutics Inc’s market cap is $74.02M.
When is Nuo Therapeutics Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Nuo Therapeutics Inc’s earnings last quarter?
Currently, no data Available
Is Nuo Therapeutics Inc overvalued?
According to Wall Street analysts Nuo Therapeutics Inc’s price is currently Overvalued.
Does Nuo Therapeutics Inc pay dividends?
Nuo Therapeutics Inc does not currently pay dividends.
What is Nuo Therapeutics Inc’s EPS estimate?
Nuo Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nuo Therapeutics Inc have?
Nuo Therapeutics Inc has 46,823,180 shares outstanding.
What happened to Nuo Therapeutics Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Nuo Therapeutics Inc?
Currently, no hedge funds are holding shares in AURX
Company Description
Nuo Therapeutics Inc
Nuo Therapeutics, Inc., a regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing primarily in the United States. Its technology separates autologous blood to produce a platelet based therapy for the chronic wound care market. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was founded in 1998 and is based in Houston, Texas.
Technical Analysis
Inovio Pharmaceuticals
―
Adaptimmune Therapeutics
―
VistaGen Therapeutics
―
Celularity
―
Surrozen
―